I am a
Home I AM A Search Login

Papers of the Week

2020 May

Radiol Case Rep



Fibromyalgia associated with repeated gadolinium contrast-enhanced MRI examinations.


Lattanzio S M, Imbesi F
Radiol Case Rep. 2020 May; 15(5):534-541.
PMID: 32180856.


We report a case of a fibromyalgia (FM) patient with an history of brain-cancer presenting signs and symptoms of gadolinium toxicity following repeated administrations of a macrocyclic contrast agent, Gadovist. In the present report, we provide evidence supporting the hypothesis of a causal relationship linking gadolinium deposition to a clinical manifestation of disease, namely fibromyalgia. We unravel a role for gadolinium in the still unknown etiology of fibromyalgia as a metal toxicity disorder. Contrast agents are routinely administered in a clinical context. It is thus possible that the patients are mistakenly believed to show complaint of their primary disease, whereas, in some instances, their symptoms are associated with gadolinium deposition.